Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia

@article{Palomaki2015ModelingRF,
  title={Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia},
  author={G. Palomaki and J. Haddow and Hamish R M Haddow and S. Salahuddin and Carl Geahchan and A. Cerdeira and S. Verlohren and F. Perschel and G. Horowitz and R. Thadhani and S. Karumanchi and S. Rana},
  journal={Prenatal Diagnosis},
  year={2015},
  volume={35},
  pages={386 - 393}
}
  • G. Palomaki, J. Haddow, +9 authors S. Rana
  • Published 2015
  • Medicine
  • Prenatal Diagnosis
  • Introduction Preeclampsia (PE) is a pregnancy-specific syndrome associated with adverse maternal and fetal outcomes. Patient-specific risks based on angiogenic factors might better categorize those who might have a severe adverse outcome. Methods Women evaluated for suspected PE at a tertiary hospital (2009–2012) had pregnancy outcomes categorized as ‘referent’ or ‘severe’, based solely on maternal/fetal findings. Outcomes that may have been influenced by a PE diagnosis were considered… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Hypertension during pregnancy remains a leading cause of maternal and foetal morbidity and mortality. The frequency (5 to 10% of pregnancies) and potential severity of these diseases… Expand
    ConditionsGestational Hypertension, Pre-eclampsia
    InterventionOther, Procedure
    Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy
    10
    Assessment, Management, and Health Implications of Early-Onset Preeclampsia.
    11
    Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches
    41

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 45 REFERENCES
    Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia
    384
    Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia
    40